Speer, Thimoteus http://orcid.org/0000-0002-2491-6393
Dimmeler, Stefanie http://orcid.org/0000-0002-1045-2436
Schunk, Stefan J.
Fliser, Danilo
Ridker, Paul M
Article History
Accepted: 2 August 2022
First Online: 5 September 2022
Competing interests
: T.S. has received consulting and speaker fees from Amgen, Astellas, Bayer, GSK, Novartis, Novo Nordisk, Sanofi and Vifor. D.F. has received consulting and speaker fees from Amgen, Astellas, Bayer, Boehringer Ingelheim, GSK, Novartis, Novo Nordisk and Vifor. P.M.R. has received research grant support from Novartis, Kowa, Amarin and Pfizer, and has served as a consultant to Corvidia, Novartis, Flame, Agepha, AstraZeneca, Janssen, Civi Biopharm, SOCAR, Novo Nordisk, Upton, Omeicos, Health Outlook, Montai Health and Boehringer-Ingelheim. The other authors declare no competing interests.